October 12, 2010
- A d v e r t i s e m e n t
The U.S. Supreme Court rejected an appeal from Pfizer Inc. and other makers of hormone replacement treatments, leaving intact a ruling that lets 123 women who developed breast cancer sue in Minnesota state court.
The appeal sought to reinstate a federal trial court ruling that dismissed 116 of the plaintiffs because their claims duplicated previously filed suits.
The issue in the Supreme Court appeal turned on the complex rules governing efforts by corporate defendants to move suits out of plaintiff-friendly state courts and into federal tribunals.